Paradromics Launches Groundbreaking Brain-Computer Interface in FDA Study

Paradromics has implanted its Connexus brain-computer interface in a Michigan woman, marking its first patient in a clinical study. The device records neural activity to translate attempted speech into text or synthesized speech. With an innovative design, it boasts an industry-leading data rate. This ambitious project aims to aid individuals with severe motor impairments. While early feasibility remains paramount, the broader vision includes AI interaction and human enhancement.